Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation

Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation

Reactivation of cytomegalovirus (CMV) or Epstein-Barr virus (EBV) is common after hematopoietic stem cell transplantation (HSCT). Previous researches have demonstrated that either CMV or EBV reactivation is associated with poor outcomes of HSCT. However, few studies investigate the impact of CMV and...

Full description

Bibliographic Details
Main Authors: Jing-Rui Zhou, Da-Yu Shi, Rong Wei, Yu Wang, Chen-Hua Yan, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Yu-Qian Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
cytomegalovirus
Epstein-Barr virus
co-reactivation
immune reconstitution
stem cell transplantation
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.620891/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2020.620891/full

Similar Items